New hope for Moms-to-Be: safer malaria drugs tested in landmark trial
NCT ID NCT06962319
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests newer antimalarial drugs to see if they work as well as the current standard treatment for malaria in early pregnancy. It involves 1,510 pregnant women in Africa. The goal is to find treatments that are both effective and safe for the mother and baby.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (UNCOMPLICATED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Unit of Nanoro (CRUN), Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO)
NOT_YET_RECRUITINGNanoro, Burkina Faso
-
KEMRI Centre for Global Health Research (CGHR)
NOT_YET_RECRUITINGKisumu, 40100, Kenya
-
Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako (USTTB),
RECRUITINGBamako, 1805, Mali